Clinical trial Recruiting at 14 sites Phase 3 Interventional Ages 18 and up

Comparing two types of blood thinners after heart surgery

Official title: The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Run by Population Health Research Institute · NCT04284839 · Data updated 2026-11-12

This study is testing which type of blood thinner is safer for people who have had heart surgery and need it to prevent strokes from atrial fibrillation.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment3500 (estimated)
SponsorPopulation Health Research Institute
Academic / other
Locations19 sites (Fitzroy, Victoria and 18 other locations)
StatusRecruiting
StartedJuly 18, 2021
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedSeptember 18, 2026
Trial IDNCT04284839 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have undergone open heart surgery within the last 10 days and have atrial fibrillation requiring anticoagulation.

Probably not a fit

Patients with mechanical valve replacements, severe renal failure, or ongoing bleeding disorders are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial compares the safety of direct oral anticoagulants (DOAC) with vitamin K antagonists (VKA) in patients who have undergone cardiac surgery and require anticoagulation due to atrial fibrillation. It involves a multi-centre, randomized controlled design, enrolling patients within 10 days post-surgery. The study aims to determine which anticoagulant is safer and more effective during the early post-operative period, addressing the high risk of stroke associated with atrial fibrillation. Approximately 36,000 adults undergo cardiac surgery in Canada annually, with a significant portion requiring anticoagulation.

Why it matters

Potential benefit: If successful, this study could identify a safer and more effective anticoagulation strategy for patients after cardiac surgery, potentially reducing the risk of stroke.

How similar studies have gone: Previous studies have shown varying success with anticoagulation strategies in similar populations, but this specific comparison of DOAC versus VKA in the post-operative setting is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years at the time of enrolment,
2. Open heart surgery in the last 10 days,
3. Atrial fibrillation requiring anticoagulation (including pre-existing or post-operative atrial fibrillation),
4. Informed consent from either the patient or a substitute decision-maker.

Exclusion Criteria:

1. Mechanical valve replacement,
2. Antiphospholipid syndrome (triple positive),
3. Severe renal failure (Cockcroft-Gault equation; creatinine clearance \<15 ml/min),
4. Known significant liver disease (Child-Pugh classification B and C),
5. Left ventricular thrombus,
6. Ongoing bleeding, hemorrhagic disorders, or bleeding diathesis,
7. Known contraindication for any DOAC or VKA,
8. Women who are pregnant, breastfeeding, or of childbearing potential,
9. Surgery including left ventricular assist device implantation or cardiac transplantation,
10. Previously enrolled in this trial,
11. Follow-up not possible,
12. History of moderate or severe mitral valvular lesion (stenosis or regurgitation) that is not corrected during index cardiac surgery.

Where it's running

  • St Vincent's Hospital Melbourne
    Fitzroy, Victoria, Australia
    Recruiting
  • University of Alberta Hospital
    Edmonton, Alberta, Canada
    Recruiting
  • University of British Columbia
    Vancouver, British Columbia, Canada
    Recruiting
  • St. Boniface Hospital
    Winnipeg, Manitoba, Canada
    Recruiting
  • Health Science Centre
    St. John's, Newfoundland and Labrador, Canada
    Recruiting
  • Health Sciences North Research Institute
    Greater Sudbury, Ontario, Canada
    Recruiting
Show 13 more locations
  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting
  • Sunnybrook Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Toronto General Hospital
    Toronto, Ontario, Canada
    Recruiting
  • Montreal Heart Institute
    Montreal, Quebec, Canada
    Recruiting
  • Hôpital Sacré-Coeur de Montréal
    Montreal, Quebec, Canada
    Recruiting
  • IUCPQ-ULaval
    Québec, Quebec, Canada
    Recruiting
  • University Hospital Jena
    Jena, Thuringia, Germany
    Recruiting
  • University Medical Center Hamburg-Eppendorf
    Hamburg, Germany
    Recruiting
  • Royal Melbourne Hospital, University of Melbourne
    Parkville, Victoria, Australia
    Not yet recruiting
  • Saint John Regional Hospital
    Saint John, New Brunswick, Canada
    Active not recruiting
  • Heart Center Leipzig
    Leipzig, Saxony, Germany
    Active not recruiting
  • University Hospital Bonn Heart Center
    Bonn, Germany
    Active not recruiting
  • West-German Heart and Vascular Center, University of Duisburg-Essen
    Essen, Germany
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Head-of-bed position after clot-removal stroke therapy

    This study tests whether keeping the head of the bed flat (0 degrees) after thrombectomy improves recovery compared with a raised position in adults who had an ischemic stroke due to large vessel blockage.

    Recruiting at 2 sites Population Health Research Institute · Greater Sudbury, Ontario and 1 other locations · NCT07367633

  • Monitoring heart rhythm after noncardiac surgery

    This study is testing if wearing a portable heart monitor for up to 14 days after noncardiac surgery can help find heart rhythm problems that are often missed, to improve care for patients.

    Recruiting at 2 sites Population Health Research Institute · Hamilton, Ontario and 5 other locations · NCT06519747

  • Registry for Calcium Release Deficiency Syndrome

    This study is trying to gather information about Calcium Release Deficiency Syndrome to better understand it and find the best ways to treat people with this heart condition caused by RYR2 gene changes.

    Recruiting at 22 sites Population Health Research Institute · San Francisco, California and 21 other locations · NCT06508164

  • Surgical procedure to prevent heart rhythm issues after cardiac surgery

    This study is testing a surgical procedure to see if it can help prevent heart rhythm problems after heart surgery for patients who haven't had these issues before.

    Recruiting at 15 sites Population Health Research Institute · Louisville, Kentucky and 18 other locations · NCT06486636

  • Using patients' own blood to reduce transfusion needs after heart surgery

    This study is testing whether using patients' own blood during heart surgery can help reduce the need for blood transfusions compared to the usual method.

    Recruiting at 4 sites Population Health Research Institute · Winnipeg, Manitoba and 3 other locations · NCT06230198

  • Evaluating a diagnostic test for Calcium Release Deficiency Syndrome

    This study is testing a new way to diagnose Calcium Release Deficiency Syndrome by looking at how the heart responds to fast pacing, aiming to make diagnosis easier for patients with this condition and similar heart issues.

    Recruiting at 21 sites Population Health Research Institute · San Francisco, California and 20 other locations · NCT06188689

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.